Clover Health/$CLOV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clover Health
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Ticker
$CLOV
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
570
ISIN
US18914F1030
Website
Clover Health Metrics
BasicAdvanced
$1.5B
-
-$0.05
1.93
-
Price and volume
Market cap
$1.5B
Beta
1.93
52-week high
$4.87
52-week low
$1.01
Average daily volume
6.3M
Financial strength
Current ratio
1.537
Quick ratio
1.383
Profitability
EBITDA (TTM)
-22.906
Gross margin (TTM)
26.37%
Net profit margin (TTM)
-1.69%
Operating margin (TTM)
-1.64%
Revenue per employee (TTM)
$2,610,000
Management effectiveness
Return on assets (TTM)
-2.43%
Return on equity (TTM)
-7.75%
Valuation
Price to revenue (TTM)
0.984
Price to book
4.48
Price to tangible book (TTM)
4.52
Price to free cash flow (TTM)
-168.606
Free cash flow yield (TTM)
-0.59%
Free cash flow per share (TTM)
-1.76%
Growth
Revenue change (TTM)
15.62%
Earnings per share change (TTM)
-84.57%
3-year revenue growth (CAGR)
-10.53%
3-year earnings per share growth (CAGR)
-66.91%
What the Analysts think about Clover Health
Analyst ratings (Buy, Hold, Sell) for Clover Health stock.
Bulls say / Bears say
Clover Health reported a 27% year-over-year increase in Medicare Advantage membership, surpassing 100,000 members, with approximately 95% enrolled in its flagship 4-Star PPO plan, indicating strong market demand and member satisfaction. (globenewswire.com)
The company achieved a significant improvement in its financial performance, reporting a net loss of $1.3 million in Q1 2025, a substantial reduction from the $23.2 million loss in the same period the previous year, reflecting effective cost management and operational efficiency. (tradingview.com)
Clover Health's strategic decision to exit the ACO REACH program allows it to focus resources on its core Medicare Advantage insurance business and the Clover Assistant platform, aiming to achieve profitability on an Adjusted EBITDA basis for the full year 2024. (healthtowealthventures.blog)
Leerink Partners downgraded their Q1 2025 earnings per share estimates for Clover Health to a loss of $0.07, down from a previous estimate of $0.03, indicating concerns about the company's near-term profitability. (etfdailynews.com)
Short interest in Clover Health increased by 9.0% as of January 15, 2025, suggesting that a growing number of investors are betting against the stock, potentially reflecting skepticism about the company's future performance. (theenterpriseleader.com)
Despite reporting a net loss of $1.3 million in Q1 2025, the company's total revenues increased by 33.3% compared to the same period last year, driven by a 30% growth in membership, which may raise concerns about the sustainability of growth without achieving profitability. (tradingview.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
Clover Health Financial Performance
Revenues and expenses
Clover Health Earnings Performance
Company profitability
Clover Health News
AllArticlesVideos
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
GlobeNewsWire·2 months ago
Clover Health Announces Changes to Board of Directors
GlobeNewsWire·2 months ago
Clover Health to Participate in Upcoming Investor Conferences
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Clover Health stock?
Clover Health (CLOV) has a market cap of $1.5B as of June 21, 2025.
What is the P/E ratio for Clover Health stock?
The price to earnings (P/E) ratio for Clover Health (CLOV) stock is 0 as of June 21, 2025.
Does Clover Health stock pay dividends?
No, Clover Health (CLOV) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next Clover Health dividend payment date?
Clover Health (CLOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Clover Health?
Clover Health (CLOV) has a beta rating of 1.93. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.